Financial Analysis of Listed Companies of Biological Vaccine Companies: Take D Bio for example

Shaomeng Yang

doi:10.54097/fbem.v9i2.8999

Authors

Shaomeng Yang

DOI:

https://doi.org/10.54097/fbem.v9i2.8999

Keywords:

Biological Vaccines, Public Companies, Financial Analysis, Biotechnology, New Crown Vaccines.

Abstract

Financial analysis is an important tool for enterprises to improve management and optimize economic decisions. The analysis of corporate financial reports can provide directions and clues for improving management and provide decision support for users of financial report information. In this paper, we will take D Bio as an example and analyze its financial indicators to assess its solvency, operating capacity, profitability and growth capacity. The problems of the company's financial situation are pointed out and recommendations are given in a targeted manner to improve the company's competitiveness.

Downloads

Download data is not yet available.

References

Li Junmei, Li Jimin. Discussion of financial analysis index system [J]. Journal of Shanxi University of Finance and Economics, 2009,(S1):174.

Zhou Yihong, Kong Long. Experimental evaluation index system of enterprise financial analysis [J]. Journal of Northwest College of Nationalities,1998(02):43-49.

Zhang Xianzhi. Thinking about building a financial analysis system in China[J]. Accounting Research,2001,(06):33-39.

Shi Guozhu. On the importance of comprehensive application of financial analysis indexes of listed companies[J]. East China Economic Management, 2008,(03):93-95.

Chen Juan. Research on the application of financial analysis: the case of Dongguan Yuanmeng Home Textiles Co. Research on financial issues,2015,(S1):91-93.

Zhu Hongquan,Ying Xiaoxiao. Are dual-listed stocks more valuable for investment? -- A comparative analysis based on H+A shares vs. A shares[J]. Journal of Nanjing Audit University, 2019, 16(02):39-48.

Han Yonghui, Wei Dongming, Tan Rui. Research on investment value assessment of countries along the "Belt and Road"-an analysis of GPCA model-based measurement[J]. International Economic and Trade Exploration, 2019, 35 (12): 41-56.

Yu Chunxia, Manru, Zou Zhiqin. Research on dynamic evaluation of investment value of listed companies in artificial intelligence industry based on entropy-weight-TOPSIS[J]. Industrial Technology Economics,2020,39(12):138-146.

Chen Shujing. Financial analysis of listed companies in the new energy industry--example of XX Energy Company[J]. Journal of Southeast University (Philosophy and Social Science Edition), 2018, 20(S1):9-12.

Li Shouwen. How stock investors analyze the financial reports of listed companies [J]. Journal of Hainan University (Social Science Edition), 1999(04):77-81.

Li Cunhua, Wang Zhiqing. An empirical study of financial investment value based on high-tech manufacturing companies in A-shares[J]. Industrial Technology Economics, 2018, 37(09): 107-113.

Zhang Ran, Wang Rongfei, Wang Shenghua. Analyst correction information, fundamental analysis and future stock returns[J]. Financial Research,2017,(07):156-174.

Ji Yuwei, Wang Haiyun, Yu Guifang, Chen Yuanyuan. Research on industrial technology roadmap in the field of vaccines in Beijing[J]. Technology Economics, 2023, 42(02): 155-165.

Yao Zhenghai. Research on basic issues of financial report analysis [J]. Contemporary Finance and Economics, 2003, (09): 120-122.

Yuan Yunxiao, Wang Baohai, Wang Yunpeng. An empirical analysis of operational efficiency of Chinese biotechnology listed companies--based on DEA model and Malmquist index model[J]. Science and Technology Management Research, 2019, 39 (02):48-54.

Fan Yongxian, Chen Long, Zhang Xing. Path options for stimulating venture capital to support the development of biological and pharmaceutical industries[J]. Yunnan Social Science,2021,(05):84-89.

Cao Xiaoli. Financial analysis methods and problems in financial analysis[J]. Research on financial issues, 2014, (S2): 73-75.